Steven D Young

This inventor holds 34 USPTO granted patents and 1 EPO patent, primarily in HIV Integrase Inhibitors. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Other. Active years: 1985-2010.

USPTO Granted Patents = 34

% Patents Active = 85.3

EPO Patents = 1

Average Co-Inventor Count = 3.6

ph-index = 16

Forward Citations = 675(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

2 out of 834,307

Other

patents

Years Active: 1985-2010

Loading Chart...

Areas of Expertise:

HIV Integrase Inhibitors

Calcium Channel Blockers

Farnesyl-Protein Transferase

Quinazolinone Antagonists

Arylheteroaryl Inhibitors

Alpha1A Adrenergic Antagonists

Biaryl Substituted Imidazole

Fibrinogen Receptor Antagonists

Dioxobenzocyclo-Hepta-Pyridine

Spiro Hexahydro Arylquinolizines

Substituted Indeno Pyridines

Crystal Forms

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7745452 - Quinazolinone T-type calcium channel antagonists (2010-06-29),

2. 7452893 - 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists (2008-11-18),

3. 7279487 - Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors (2007-10-09),

4. 6939964 - Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (2005-09-06),

5. 6921759 - Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors (2005-07-26),

6. 6919351 - Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors (2005-07-19),

7. 6841558 - Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors (2005-01-11),

8. 6639071 - Crystal Forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (2003-10-28),

9. 6380249 - HIV integrase inhibitors (2002-04-30),

10. 6306891 - HIV integrase inhibitors (2001-10-23),

11. 6262055 - HIV integrase inhibitors (2001-07-17),

12. 6093737 - Inhibitors of farnesyl-protein transferase (2000-07-25),

13. 6080870 - Biaryl substituted imidazole compounds useful as farnesyl-protein (2000-06-27),

14. 6077853 - Inhibitors of farnesyl-protein transferase (2000-06-20),

15. 5990107 - Fibrinogen receptor antagonist prodrugs (1999-11-23),

Hello! How may I help you today in the sphere of innovations, inventions, inventors, patent attorneys, and patents?

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]